TY  - GEN
AU  - Skoda-Smith,S
AU  - Douglas,V K
AU  - Mehta,P
AU  - Graham-Pole,J
AU  - Wingard,J R
TI  - Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab
SN  - 0268-3369
PY  - 2001///0628
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Child, Preschool
KW  - Disease-Free Survival
KW  - Haplotypes
KW  - immunology
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Lymphoma, B-Cell
KW  - etiology
KW  - Lymphoproliferative Disorders
KW  - Major Histocompatibility Complex
KW  - genetics
KW  - Male
KW  - Remission Induction
KW  - Rituximab
KW  - Severe Combined Immunodeficiency
KW  - complications
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1702792
ER  -